Latest Tri Locum Partners LP Stock Portfolio
Tri Locum Partners LP Performance:
2025 Q1: 0.11%YTD: 0.11%2024: 40.66%
Performance for 2025 Q1 is 0.11%, and YTD is 0.11%, and 2024 is 40.66%.
About Tri Locum Partners LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Tri Locum Partners LP reported an equity portfolio of $194.9 Millions as of 31 Mar, 2025.
The top stock holdings of Tri Locum Partners LP are CI, MCK, SLNO. The fund has invested 12.5% of it's portfolio in THE CIGNA GROUP and 9.3% of portfolio in MCKESSON CORP.
The fund managers got completely rid off ZIMMER BIOMET HOLDINGS INC (ZBH), NATERA INC (NTRA) and VERONA PHARMA PLC (VRNA) stocks. They significantly reduced their stock positions in STEVANATO GROUP S P A, AXSOME THERAPEUTICS INC (AXSM) and EVOLUS INC (EOLS). Tri Locum Partners LP opened new stock positions in MCKESSON CORP (MCK), SOLENO THERAPEUTICS INC (SLNO) and GILEAD SCIENCES INC (GILD). The fund showed a lot of confidence in some stocks as they added substantially to PRAXIS PRECISION MEDICINES I (PRAX) and THE CIGNA GROUP (CI).
The top stock holdings of Tri Locum Partners LP are CI, MCK, SLNO. The fund has invested 12.5% of it's portfolio in THE CIGNA GROUP and 9.3% of portfolio in MCKESSON CORP.
The fund managers got completely rid off ZIMMER BIOMET HOLDINGS INC (ZBH), NATERA INC (NTRA) and VERONA PHARMA PLC (VRNA) stocks. They significantly reduced their stock positions in STEVANATO GROUP S P A, AXSOME THERAPEUTICS INC (AXSM) and EVOLUS INC (EOLS). Tri Locum Partners LP opened new stock positions in MCKESSON CORP (MCK), SOLENO THERAPEUTICS INC (SLNO) and GILEAD SCIENCES INC (GILD). The fund showed a lot of confidence in some stocks as they added substantially to PRAXIS PRECISION MEDICINES I (PRAX) and THE CIGNA GROUP (CI).
Tri Locum Partners LP Annual Return Estimates Vs S&P 500
Our best estimate is that Tri Locum Partners LP made a return of 0.11% in the last quarter. In trailing 12 months, it's portfolio return was 21.22%.
New Buys
| Ticker | $ Bought |
|---|---|
| mckesson corp | 18,133,000 |
| soleno therapeutics inc | 16,785,000 |
| gilead sciences inc | 10,023,200 |
| illumina inc | 9,578,640 |
| insmed inc | 7,770,820 |
| nuvalent inc | 6,795,910 |
| ascendis pharma a/s | 5,038,180 |
| blueprint medicines corp | 4,425,500 |
New stocks bought by Tri Locum Partners LP
Additions
| Ticker | % Inc. |
|---|---|
| praxis precision medicines i | 124 |
| the cigna group | 81.1 |
Additions to existing portfolio by Tri Locum Partners LP
Reductions
| Ticker | % Reduced |
|---|---|
| stevanato group s p a | -84.34 |
| argenx se | -69.37 |
| axsome therapeutics inc | -59.47 |
| evolus inc | -56.66 |
| teva pharmaceutical inds ltd | -56.21 |
| merus n v | -54.82 |
| genedx holdings corp | -54.42 |
| inspire med sys inc | -47.73 |
Tri Locum Partners LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| geron corp | -8,753,840 |
| avadel pharmaceuticals plc | -20,368,200 |
| mind medicine mindmed inc | -5,712,720 |
| verona pharma plc | -21,093,100 |
| legend biotech corp | -12,648,400 |
| zimmer biomet holdings inc | -38,977,900 |
| bristol-myers squibb co | -20,099,500 |
| janux therapeutics inc | -12,657,200 |
Tri Locum Partners LP got rid off the above stocks
Sector Distribution
Tri Locum Partners LP has about 86.4% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 86.4 |
| Others | 11 |
| 2.6 |
Market Cap. Distribution
Tri Locum Partners LP has about 44.2% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 44.2 |
| MID-CAP | 29.9 |
| SMALL-CAP | 14.9 |
| UNALLOCATED | 11 |
Stocks belong to which Index?
About 57.9% of the stocks held by Tri Locum Partners LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 42.1 |
| S&P 500 | 31.8 |
| RUSSELL 2000 | 26.1 |
Tri Locum Partners LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Tri Locum Partners LP
Tri Locum Partners LP has 22 stocks in it's portfolio. About 73.2% of the portfolio is in top 10 stocks. TEVA proved to be the most loss making stock for the portfolio. AXSM was the most profitable stock for Tri Locum Partners LP last quarter.
Last Reported on: 14 May, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AXSM | axsome therapeutics inc | 6.06 | 101,240 | 11,807,600 | reduced | -59.47 | ||
| BMY | bristol-myers squibb co | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BPMC | blueprint medicines corp | 2.27 | 50,000 | 4,425,500 | new | |||
| CI | the cigna group | 12.47 | 73,905 | 24,314,700 | added | 81.1 | ||
| EOLS | evolus inc | 1.99 | 321,802 | 3,871,280 | reduced | -56.66 | ||
| FEMY | femasys inc | 0.02 | 30,606 | 38,258 | unchanged | 0.00 | ||
| GERN | geron corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GILD | gilead sciences inc | 5.14 | 89,453 | 10,023,200 | new | |||
| IDXX | idexx labs inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ILMN | illumina inc | 4.92 | 120,729 | 9,578,640 | new | |||
| INSM | insmed inc | 3.99 | 101,859 | 7,770,820 | new | |||
| INSP | inspire med sys inc | 6.44 | 78,812 | 12,553,200 | reduced | -47.73 | ||
| JANX | janux therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| JAZZ | jazz pharmaceuticals plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| LIVN | livanova plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MCK | mckesson corp | 9.30 | 26,944 | 18,133,000 | new | |||
| MDGL | madrigal pharmaceuticals inc | 6.44 | 37,869 | 12,543,300 | reduced | -20.23 | ||
| MNMD | mind medicine mindmed inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MRUS | merus n v | 3.39 | 156,915 | 6,604,550 | reduced | -54.82 | ||
| NTRA | natera inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||